Stay updated with breaking news from Nasdaq Fdmt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) dropped 2.3% on Wednesday . The company traded as low as $26.13 and last traded at $26.13. Approximately 43,923 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 1,080,685 shares. The stock had previously closed at $26.75. Wall Street […]
4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price target boosted by Royal Bank of Canada from $35.00 to $40.00 in a research report released on Monday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. A number of other equities research analysts have also issued reports on […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) insider Scott Bizily sold 8,153 shares of 4D Molecular Therapeutics stock in a transaction on Monday, April 1st. The stock was sold at an average price of $31.78, for a total value of $259,102.34. Following the transaction, the insider now directly owns 1,737 shares of the […]
4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price objective hoisted by Jefferies Financial Group from $30.00 to $58.00 in a research report report published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. FDMT has been the topic of a number of other research reports. The Goldman Sachs […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $35.72 and last traded at $35.58, with a volume of 265016 shares trading hands. The stock had previously closed at $34.05. Analysts Set New Price Targets A number […]